Outset Medical, Inc.

NASDAQ:OM

Medical - Devices

Healthcare
$3.04 +18.16%

+$0.73 today

Market cap
$57.31M
Beta
1.94
P/E (TTM)
-1.2
EPS (TTM)
-$4.07
52W Low $3.00High $21.36

Volume 0.05M

Average 0.16M

OM Deferred Revenue

Payments received for goods or services the company will deliver within the next year.

Outset Medical, Inc.NASDAQ: OM

Deferred Revenue · Q1 FY2026 · quarter ended Mar 2026

Deferred revenue falls 4.2% from a year ago

Deferred revenue stood at $12.64M at the end of Q1 FY2026, down 4.2% from a year earlier and down 8.4% from the prior quarter. Over 3 fiscal years it compounded at +16.8% a year.

Context

  • Deferred revenue amounted to 5.1% of total assets at the end of Q1 FY2026, up 0.7 pp from a year earlier.
  • Deferred revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether deferred revenue keeps falling in the next quarterly balance sheet after a -4.2% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$12.64M-8.4% QoQ
Last fiscal yearDec 2025
$13.8M+8.2% YoY
Year agoMar 2025
$13.19M-4.2% since
Deferred Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-4.2%——
1 year+8.2%——
3-year CAGR+16.8%——
5-year CAGR——
10-year CAGR——

Deferred Revenue history

USD · from the balance sheet

Latest · FY2025
13.8M USD
Year-over-year change
+8.2%
4-year CAGR
+21.5%

Deferred Revenue vs competitors

How OM compares with its peers on the latest reported figures

  • OM's Mar 2026 deferred revenue of $12.64M is the 3rd highest of the 10 companies compared; the peer median is $5.09M.
  • Its year-over-year change of -4.2% is the 4th highest of 7, against a peer median of -5.3%.
  • Deferred revenue amounts to 5.1% of total assets for OM, versus a peer median of 1.8%.
OM Competitors Peer median
Deferred Revenue for OM and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
CATXPerspective Therapeutics, Inc.Mar 2026$26.6M ——6.5%
QTRXQuanterix CorporationMar 2026$15.19M +66.9%+33.8%4.1%
OMOutset Medical, Inc.Mar 2026$12.64M -4.2%+16.8%5.1%
VMDViemed Healthcare, Inc.Mar 2026$7.48M +10.1%+17.6%3.8%
TNYATenaya Therapeutics, Inc.Mar 2026$5.72M ——4.2%
INGNInogen, Inc.Mar 2026$5.09M -20.6%-14.7%1.8%
NNOXNano-X Imaging Ltd.Dec 2025$534K +281.4%+43.2%0.3%
SIShoulder Innovations, Inc.Mar 2026$0 ——0.0%
HSDTSolana CompanyMar 2026$0 -100.0%—0.0%
SNWVSANUWAVE Health, Inc.Mar 2026$0 -100.0%+86.3%0.0%
Peer median (excluding OM) $5.09M-5.3%+33.8%1.8%

Competitors are the stored peer set for OM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents182.35M73.22M68.51M124.01M35.01M
Short-term Investments157.14M214.28M134.82M34.67M133.94M
Net Receivables25.6M28.07M32.98M35.62M28.33M
Inventory39.19M51.48M49.22M59.39M47.61M
Other Current Assets5.53M6.6M5.7M4.53M6M
Total Current Assets409.8M373.65M291.22M258.22M250.88M
Property, Plant & Equipment (Net)20.2M21.99M18.65M12.07M9.47M
Goodwill00000
Intangible Assets00000
Long-term Investments33.31M3.31M3.33M03.83M
Tax Assets00000
Other Non-current Assets156K1.17M3.93M5.5M317K
Total Non-current Assets53.66M26.47M22.58M17.57M13.61M
Total Assets463.46M400.12M313.8M275.8M264.5M
Account Payables1.76M603K5.83M3.86M554K
Short-term Debt0001.8M0
Tax Payables00000
Deferred Revenue6.34M8.66M11.73M12.75M13.8M
Other Current Liabilities17.49M19.85M24.77M25.17M5.44M
Total Current Liabilities51.7M51.95M55.32M45.38M37.63M
Long-term Debt29.76M96.34M130.11M197.38M96.24M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)312K151K101K844K406K
Other Non-current Liabilities721K113K896K2.7M406K
Total Non-current Liabilities37.69M102.18M135.59M203.6M99.91M
Total Liabilities89.38M154.13M190.92M248.98M137.54M
Common Stock47K48K50K53K18K
Retained Earnings(625.99M)(788.95M)(961.75M)(1.09B)(1.17B)
Accumulated OCI(184K)(564K)68K42K172K
Other Stockholders Equity00000
Minority Interest00000
Total Equity374.08M245.99M122.89M26.82M126.95M
Total Debt37.81M103.23M136.19M201.86M101.25M
Net Debt(144.54M)30.01M67.68M77.84M66.24M

Outset Medical, Inc.

NASDAQ:OM

Intrinsic Alpha fair value

Locked

Current Price

$3.04

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.